Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570797
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim UniversitesiNot Yet RecruitingNot Applicable
NCT07570797Not Yet Recruiting
Not Applicable
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim...
NCT07569029
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan AntibodiesDepartment of Health and Human Services (HHS)Not Yet RecruitingPhase 1
NCT07569029Not Yet Recruiting
Phase 1
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA...Department of Health and...
NCT07571707
Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing General AnesthesiaUdayana UniversityRecruitingNot Applicable
NCT07571707Recruiting
Not Applicable
Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing Genera...Udayana University
NCT07568561
Maternal Methyl-Nutrient Status and Infant Neurodevelopment StudyFar Eastern Memorial HospitalNot Yet Recruiting
NCT07568561Not Yet Recruiting
—
Maternal Methyl-Nutrient Status and Infant Neurodevelopment StudyFar Eastern Memorial Hosp...
NCT07571824
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy SubjectsCorium Innovations, Inc.RecruitingPhase 1
NCT07571824Recruiting
Phase 1
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy...Corium Innovations, Inc.
NCT07571369
Stress Modulation and Dynamic BalanceKafrelsheikh UniversityNot Yet RecruitingNot Applicable
NCT07571369Not Yet Recruiting
Not Applicable
Stress Modulation and Dynamic BalanceKafrelsheikh University
NCT07569068
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ AdenocarcinomaRuijin HospitalRecruitingPhase 2
NCT07569068Recruiting
Phase 2
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Posit...Ruijin Hospital
NCT07570355
Pterygopalatine Ganglion Stimulation for the Treatment of Geographic AtrophyShanghai Institute of Acupuncture, Moxibustion and MeridianNot Yet RecruitingNot Applicable
NCT07570355Not Yet Recruiting
Not Applicable
Pterygopalatine Ganglion Stimulation for the Treatment of Geographic AtrophyShanghai Institute of Acu...
NCT07571213
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National Cohort of 315 042 ICU AdmissionsRegion DalarnaCompleted
NCT07571213Completed
—
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National...Region Dalarna
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07571330
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de Nuevo LeonRecruitingNot Applicable
NCT07571330Recruiting
Not Applicable
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de N...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07571798
The Difference of Two and Three Fluoroscopic Views of Sacrum for Percutaneous Sacroiliac Screw Insertion in High Energy Posterior Pelvic Ring Injured PatientsChonburi hospitalActive Not RecruitingNot Applicable
NCT07571798Active Not Recruiting
Not Applicable
The Difference of Two and Three Fluoroscopic Views of Sacrum for Percutaneous Sa...Chonburi hospital
NCT07568600
Development and Clinical Study of Burn Wound Nursing Dressing Based on Sodium Hyaluronate Carbomer Composite HydrogelThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07568600Not Yet Recruiting
Not Applicable
Development and Clinical Study of Burn Wound Nursing Dressing Based on Sodium Hy...The First Affiliated Hosp...
NCT07569094
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07569094Not Yet Recruiting
—
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital...
NCT07570498
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of Hong Kong, ShenzhenCompletedNot Applicable
NCT07570498Completed
Not Applicable
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting7 (35%)
Completed2 (10%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 13 (15%)
Phase 22 (10%)
Phase 41 (5%)